about
Antiplatelet drugs in prevention and treatment of coronary heart disease: aspirin is obligatory, quite sufficient, and safeAntiplatelet drugs in prevention of complications of arteriosclerotic diseases: it is necessary to move beyond aspirinNon ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrelRegister of acute coronary syndromes in Russia: treatment and in hospital outcomes in non-ST elevation acute coronary syndromeRegister of Acute Coronary Syndromes in Russia: Management and Inhospital Outcomes in ST Elevation Acute Coronary SyndromeEnoxaparin for the Treatment of Unstable Angina and Non-ST Segment Elevation Myocardial Infarction: the ENO-INT StudyDebates on the concomitant use of aspirin and Angiotensin converting enzyme inhibitors: will the consensus be reached?Stroke and Other Thromboembolic Complications of Atrial Fibrillation. Part III. Prevention With AspirinThe Use of Clopidogrel in Conjunction With Thrombolytic Therapy in PatientsWith ST-Elevation Acute Myocardial Infarction.Do low risk patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel need abciximab infusion? Results of ISAR-REACT studyStroke and other tromboembolic complications in atrial fibrillation. Part I. Prevalence and risk factorsAspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasisComparative analysis of antiarrhythmic action and electrophysiological effects of a new benzodiazepine derivative gidazepam and ethacizin in arrhythmias of various genesisDeviation of activated partial thromboplastin time from optimal level after 12 hours of intravenous infusion of unfractionated heparin -- an independent predictor of recurrence and unfavorable 30-day prognosis in patients with myocardial infarctionDiabetes mellitus as a problem of modern cardiologyGenetic basis of individual sensitivity to antiplatelet drugsIndirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndromeUse of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunctionInteraction of angiotensin converting enzyme inhibitors with nonsteroidal antiinflammatory drugsProspective analysis of conservative treatment of acute coronary syndromeFeasibility of implementation of guidelines for the management of acute coronary syndrome in cardiac unit of a community hospitalAspirin in primary prevention of ischemic heart diseaseEffect of calcium antagonists on long-term prognosis of patients with myocardial infarctionDevelopment of myocardial infarction in aspirin-treated unstable angina pectoris. Repeated studies of platelet aggregation and of the thromboxane-prostacyclin systemStent thrombosis in patients with myocardial infarctionMarkers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatinNon ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrelNon ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasisCombination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMAEarly use of gemfibrozil in patients with non ST Elevation acute coronary syndrome. Changes of markers of inflammation and von Willebrand factorEffectiveness and safety of clopidogrel bisulfate in complex therapy of patients with acute coronary syndrome with ST segment elevationDiagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600mg (ISAR-COOL)Favorable effect of trimetazidine on clinical state and left ventricular function postinfarction period.Relationship Between Lipid Lowering and Changes of Hemostasis and Inflammation During Use of Statins in Non-ST Elevation Acute Coronary SyndromeComparative anti-arrhythmia effectiveness of activators of body stress-limiting systems in patients with arrhythmiaStroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of strokeAspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials)Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatinClinical aspects and diagnosis of Ebstein's anomaly
P1433
Q28165348-B0D447EC-B8B1-44F8-AC0F-B7C4C83842B5Q28165350-94CC19A7-5C04-44D0-BFD2-511C660D4273Q28165916-317F4C2F-EACB-4FD3-BA61-EC563B4264DFQ28166462-A5D2C2F9-B1FF-4328-BD7F-9BF629ED4656Q28168433-D7A2FE59-5C0E-4F4E-827B-DE7ED92EDDD8Q28169059-EB9DED36-F2F5-463F-B2C9-8F72CF297053Q28169061-6D42EA84-63DE-418C-8D57-66B0E2F61376Q28169062-5C9F8A9F-2385-4C63-957C-87FA308FE144Q28171116-77DFA1B7-A3D6-4ACF-B2E2-9BA07150D423Q28171189-DE0E49F8-5382-4493-9568-9B55414B15FBQ28171191-653DF424-78E0-48AB-B961-C175E1AC62FCQ28186544-4639125C-78BD-4F49-B204-FC84BB3E6E3DQ28190969-D761CCF6-ED6F-4DAC-97E1-12D5FAD7A179Q28192778-6B2D43FF-EA24-461F-81FD-6A40AC1744F6Q28192783-0881B509-75FD-49BF-824B-154C26A09B0FQ28192786-FE5B6585-F7CE-4767-987C-5D9B04CAAAA7Q28193942-440A4F41-7AC8-4986-BC81-34889F9B7867Q28194477-AF3119BF-EBFE-4554-95C1-77B2FC09FBF0Q28194478-9C31F669-ECA1-4774-8624-14BA1BE0397DQ28194481-DA1DDD8E-C6C1-44A6-8414-BE97E1FF8865Q28194483-0AB0FE19-14BA-4E45-AD9B-17F5F0210D82Q28194484-22D483C5-71DB-4037-A72B-D1FC63527F05Q28194485-4515AA1E-A4C9-463C-9AE9-7C9DE9212AEDQ28196805-1A07E094-B5F4-43D7-AA64-D48AA7704DC5Q28196906-861D8404-7873-4A97-B3FB-9E186073B7A7Q28196908-4EA5F012-F861-401A-B752-05B731C0E0D3Q28196910-1BA13B69-AA56-415C-9D5A-FA3C923B3E90Q28196911-6C3B45C8-24F3-4DF5-97E1-7C3421AA9EC2Q28199623-70DC9048-BD4B-41EF-AC2C-4796357BC5A6Q28199927-EAFB8548-3F13-450C-96C1-A6659C3D24F6Q28199931-316E436D-2D5F-4EDA-B2C5-F4F053DB2AFDQ28208897-8657D106-07D3-4866-B461-E865DE477DCEQ28208922-8870D7ED-D140-4B31-9E3E-6DAFED7DF764Q28211829-8AB713E8-4D95-40C6-9AF6-EE95F72C9ACAQ28212064-EF973112-24AB-4FD7-BC0B-A4A7B93B4E71Q28212259-E190932B-4582-49DA-9A27-44481B1CEA18Q28217530-67A25028-4CFC-403A-80F7-3F0788ADCAF5Q28218197-6DB89316-4E63-445F-BC88-B2BC66912CE4Q28222219-E23C4557-2A0F-47D0-BF7D-25A6957F0D50Q28258186-46C37A2C-E757-480C-B3A4-3604C210BF39
P1433
description
Russian medical journal
@en
czasopismo naukowe
@pl
revista científica
@es
vědecký časopis
@cs
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Cardiology
@ast
Cardiology
@da
Cardiology
@en
Cardiology
@fi
Cardiology
@fr
Cardiology
@it
Cardiology
@nb
Cardiology
@nl
Cardiology
@nn
Cardiology
@sv
type
label
Cardiology
@ast
Cardiology
@da
Cardiology
@en
Cardiology
@fi
Cardiology
@fr
Cardiology
@it
Cardiology
@nb
Cardiology
@nl
Cardiology
@nn
Cardiology
@sv
altLabel
Kardiologiia
@en
Kardiologiya
@en
prefLabel
Cardiology
@ast
Cardiology
@da
Cardiology
@en
Cardiology
@fi
Cardiology
@fr
Cardiology
@it
Cardiology
@nb
Cardiology
@nl
Cardiology
@nn
Cardiology
@sv
P3181
P1055
P1058
P1156
P1250
P1277
P1476
Cardiology
@und